ONCOTEC
ONCOTEC Pharma is a leading biopharmaceutical company headquartered in GE, specialising in the development of innovative therapies for cancer treatment. Founded in 2001, ONCOTEC has established a strong presence in Europe and beyond, focusing on the research and development of targeted therapies and personalised medicine. The company is renowned for its unique approach to oncology, offering a range of products and services that address unmet medical needs in cancer care. ONCOTEC's commitment to advancing cancer treatment has positioned it as a key player in the biopharmaceutical industry, with notable achievements in clinical trials and partnerships that enhance its market position. With a focus on improving patient outcomes, ONCOTEC continues to push the boundaries of cancer research and therapy.
DitchCarbon Score
How does ONCOTEC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ONCOTEC's score of 11 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ONCOTEC's reported carbon emissions
As of the latest available data, ONCOTEC has not reported specific carbon emissions figures. However, the company is committed to achieving net-zero emissions across all scopes by 2050, with a starting point in 2023. This long-term commitment aligns with industry standards and reflects ONCOTEC's dedication to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. ONCOTEC's commitment to net-zero emissions indicates a proactive approach to reducing its carbon footprint, although specific reduction targets or interim goals have not been disclosed. The company is actively engaged in initiatives to align with the Science Based Targets initiative (SBTi), demonstrating its commitment to sustainable practices and climate responsibility. Overall, while detailed emissions data is currently unavailable, ONCOTEC's long-term climate commitments position it as a forward-thinking player in the industry, aiming to contribute positively to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ONCOTEC is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
